Evidence map›Paper›PMID 29323611›Full record

ArticleAnnual review of public health2018

Harm Minimization and Tobacco Control: Reframing Societal Views of Nicotine Use to Rapidly Save Lives.

David B Abrams, Allison M Glasser, Jennifer L Pearson, Andrea C Villanti, Lauren K Collins, Raymond S Niaura

Abstract read
In one paragraph

Article in Annual review of public health, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 160 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
160citing papers in PubMed, 3 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

160 citing papers in PubMed, 3 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Trial
  5. Evaluation of Dual Use: Real Time Reductions in Combustible Cigarette Smoking During Co-Occurring Use of E-Cigarettes.Nicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco · 2025
    Trial
  6. Trial
  7. Trial
  8. Manipulation of Menthol and Nicotine Content in Cigarettes: Effects on Smoking Behavior and Toxicant Exposure in Women Menthol Smokers.Nicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco · 2023
    Trial
  9. Trial
  10. Trial
  11. Trial
  12. Trial
  13. Trial
  14. Trial
  15. Trial
  16. Trial
  17. Past-Month Tobacco and Cannabis Co-Use by Chronic Disease and Sociodemographic Factors Among U.S. Adults 65+ Years (2021-2023).Journal of applied gerontology : the official journal of the Southern Gerontological Society · 2026
    Article
  18. Article
  19. Review
  20. Article

100 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

David B AbramsCollege of Global Public Health, New York University, New York, NY 10012, USA; email: David.B.Abrams@nyu.edu , niaura@nyu.edu.
Allison M GlasserSchroeder Institute for Tobacco Research and Policy Studies, Truth Initiative, Washington, DC 20001, USA; email: ag6507@nyu.edu , katz.laurenk@gmail.com.
Jennifer L PearsonSchool of Community Health Sciences, University of Nevada, Reno, Nevada 89557, USA; email: jennipearson@unr.edu.
Andrea C VillantiVermont Center on Behavior and Health, University of Vermont, Burlington, Vermont 05401, USA; email: andrea.villanti@uvm.edu.
Lauren K CollinsSchroeder Institute for Tobacco Research and Policy Studies, Truth Initiative, Washington, DC 20001, USA; email: ag6507@nyu.edu , katz.laurenk@gmail.com.
Raymond S NiauraCollege of Global Public Health, New York University, New York, NY 10012, USA; email: David.B.Abrams@nyu.edu , niaura@nyu.edu.

Funding

EMA and Lab Assessment of Nicotine Dependence Among Dual End UsersK01DA037950 · NIDA · UNIVERSITY OF NEVADA RENO · PI PEARSON, JENNIFER LYNN · 2014 to 2017
$611k
NIDA NIH HHS K01 DA037950
6 · The paper itself

Abstract

Inhalation of the toxic smoke produced by combusting tobacco products, primarily cigarettes, is the overwhelming cause of tobacco-related disease and death in the United States and globally. A diverse class of alternative nicotine delivery systems (ANDS) has recently been developed that do not combust tobacco and are substantially less harmful than cigarettes. ANDS have the potential to disrupt the 120-year dominance of the cigarette and challenge the field on how the tobacco pandemic could be reversed if nicotine is decoupled from lethal inhaled smoke. ANDS may provide a means to compete with, and even replace, combusted cigarette use, saving more lives more rapidly than previously possible. On the basis of the scientific evidence on ANDS, we explore benefits and harms to public health to guide practice, policy, and regulation. A reframing of societal nicotine use through the lens of harm minimization is an extraordinary opportunity to enhance the impact of tobacco control efforts.

Indexed as

Harm ReductionCigarette SmokingHumansNicotinePublic HealthTobacco ProductsUnited StatesVapingNicotinee-cigarettesharm minimizationnicotinesmokingtobacco

Identifiers

PMID29323611
PMCPMC6942997

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.